Catalogo dei Corsi di studio

Informazioni personali

Nome: GABRIELLA d ETTORRE
Data di nascita: 09/05/1968
Luogo: Lecce
Citttadinanza: Italiana
Residenza: Via Lorenzo Il Magnifico,148 Rome 00162 (Italy)
Tel: +0649970801
E-mail: gabriella.dettorre@uniroma1.it

Esperienze lavorative

dal 2017 a oggi
UNIVERSITA DI ROMA SAPIENZA
Professore associato in Malattie Infettive

Dal 2002 a oggi
AZIENDA POLICLINICO UMBERTO I - ROMA
Dirigente medico, consulente di malattie infettive

Dal 2000 al 2002
ISTITUTO SUPERIORE DI SANITA
Vincitore di Felloship - Grant AIDS

EDUCATION AND TRAINING

1995 UNIVERSITY SAPIENZA ROME
Degree MD in Medicine and Surgery

1999 UNIVERSITY SAPIENZA ROME
Degree Specialization in Infectious Diseases

2002 THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER - DALLAS
Degree MSc MASTER Infectious Diseases

2004 UNIVERSITY SAPIENZA ROME
PhD in infectious diseases and immunology
2008 HOSPITAL SAN CARLOS III MADRID
Degree MSc in Management of HIV/HCV coinfection

2009 AMERICAN SOCIETY FOR COLPOSCOPY AND CERVICAL PATHOLOGY (ASCCP)
Degree MSc in HIGH RESOLUTION ANOSCOPY

TEACHING ASSIGNMENTS
Dal 2005 to 2016
Infectious diseases at Course of Health Promotion and Security of Faculty of Medicine of Sapienza University of Rome

Dal 2018 a oggi
Infectious diseases at Faculty of Medicine of Sapienza University of Rome

Dal 2018 a oggi
Infectious diseases at PhD School in Infectious Diseases, Microbiology and Public Health of Sapienza University of Rome

Dal 2018 a oggi
Infectious diseases at Course of Health Promotion and Security of Faculty of Medicine of Sapienza University of Rome

GRANTS
2016 - Fellowship program Gilead 2016 per il progetto PRIMO Project: Infectious Disease and Movement Program: study of the effects of physical activity on HIV infection euro 20.000
2016 - Fellowship program Gilead 2016 ( Ethical grant ) euro 5.000
2018 - Fellowship program Gilead 2018 per il progetto Role of HPV on life quality of HIV positive MSM euro 25.000
2018 - progetto di Ateneo Study of cardiovascular disease in HIV-positive patients: clinical implications of changes in the microbiota and serological markers of immunoactivation - Role PI (euro 10.000)
2018 - progetto di Ateneo Correlation Between Circulating ANGPTL2 Levels and Immunoactivation Status in a Cohort of HIV-Positive Patients (euro 1.000)
2018 - progetto di Ateneo Bacterial/viral interactions in infection and immunity: application of the flow cytometry technology in different clinical settings (euro 63.000)
2019 - progetto di Ateneo Targeting endocrine, metabolic, and vascular dysfunction in HIV : pharmacological modulation of the phosphodiesterase type-5 in clinical and experimental models (euro 29.000)
2020 - progetto di Ateneo Oral bacteriotherapy decontamination for the prevention of Ventilator Associated Pneumonia (VAP) in Intensive Care Unit patients (euro 23.787)
2020 progetto di Ateneo Profile of the immune response of MBCs in the COVID-19 patient (euro 2.000)

Sperimentatore clinico/PI :

1998-2002 - Clinical investigator in National Register of HIV-infected people being treated with protease inhibitors (Italian Institute of Health - National AIDS Research Program 1998)
1999-2000 - Clinical investigator in ACTG 388 (National Institute of Health NIH - Bethesda US)
1999-2000 - Clinical investigator in ISS-PART (Italian Institute of Health - National AIDS Research Program 1999)
1999-2000 - Clinical investigator in ACTG 384 (National Institute of Health NIH - Bethesda US and Italian Institute of Health - National AIDS Research Program 1999)
1999-2000 - Clinical investigator in: "Abbott Protocol M05-730 "
2005-2006 - Clinical investigator in: "The SKAN Study
2005-2006 - Clinical investigator in: " UK-427,857"
2006-2007 - Clinical investigator in: "MV16721
2006-2007 - Clinical investigator in: BI 1182.17-Resist 1 Rollover
2007-2008 - Clinical investigator in: Pfizer protocol A4001050: a multicenter open label expanded access trial of Maraviroc
2008-2016 - Clinical investigator in: An international multicenter prospective observational study of the safety of maraviroc used with optimized background therapy in treatment experienced HIV-1 infected patients-POEM
2008-2009 - Clinical investigator in: Prospective Observational Study for the Optimization of Therapy of HIV / HCV coinfection: O.P.E.R.A.
2009-2012 Clinical investigator in: "NEAT 001/ANRS 143"
2009-2016: Clinical investigator in: "ATLAS pilot study
2009 a oggi PI in progetto Anal HPV lesions in MSM HIV population in collaboration with UCSF San Francisco (Prof J. Palefsky)
2009 a oggi PI in progetto Mucosal innate immunity in PLWH in collaboration with Emory University Atlanta US (Prof G. Silvestri)
2009 a oggi PI in progetto Innovative therapies in PLWH in collaboration with NIH Bethesda US (Prof J. Brenchley)
2010 2013 Clinical investigator in: New Anti-HIV Inhibitors - NIA Cohort Study (Italian Institute of Health)
2010 2011 Clinical investigator in: Intervention program for strengthening adherence to potent antiretroviral therapy (HAART), improving the doctor-patient relationship and increasing knowledge about HIV infection in people with this disease. HIV-Vision protocol
2012 a oggi: Clinical investigator in: Interleukin 32: molecular expression, epigenetic regulation and biological activities in human immunodeficiency virus-1 infection in collaboration with Istituto Pasteur Italia-Cenci Bolognetti
2013 2016: Clinical investigator in: RANIA Study - Switching from regimens consisting of a RTV-boosted protease inhibitor plus TDF/FTC to a combination of RAltegravir plus NevIrapine and - Ha partecipato allo studio multicentrico nazionale RANIA Study - Switching from regimens consisting of a RTV-boosted protease inhibitor plus TDF/FTC to a combination of RAltegravir plus NevIrapine and IAmivudine in HIV patients with suppressed viremia and impaired renal function (RANIA Study)
2013 a oggi: Clinical investigator in: Finalized research In collaboration with the L. Spallanzani Research Institute entitled: "A registri of severe malaria in returning travelers from endemic countries: clinical outcome and adverse events including haematological and pharmacokinetic data. Network for severe Malaria treatment-nomai study"
2014 a oggi - Clinical investigator in Acute infection in HIC InAction
2014 a oggi - Clinical investigator in Interferon lamba activation and epigenetic regulatuon during progression of Human Papilloma Virus infection to anogenital cancer" (Faculty project of Sapienza University with grant)
2014 a oggi PI in clinical trial "Effects of probiotics on Microbial translocation and immune activation markers in HIV positive patients on combined antiretroviral therapy (Probio-HIV)". Clinical Trial Gov. NCT02164344 in collaboration with NIH Bethesda US (Prof J. Brenchley)
2014 - a oggi PI in clinical trial Study of recovery of intestinal CD4+ and Th17 T cells in HIV infected individuals on short term antiretroviral therapy" Clinical Trial Gov identifier: NCT02097381 in collaboration with Emory University Atlanta US (Prof G. Silvestri)
2014 a oggi PI in clinical trial "Effects of VSL#3 on neurocognitive profile of HIV patients"Clinical Trial Gov identifier NCT02276326". Clinical Trial Gov. NCT02164344 in collaboration with NIH Bethesda US (Prof J. Brenchley)
2015 a oggi - Clinical investigator in Interplay between type I Interferon activation and viral burden in determina differences in cardiovascular risk in HIV-1 patients" (Faculty project of Sapienza University with grant)
2016 a oggi - Clinical investigator in PRADAR A prospective, randomized, open-label trial of two abacavir/lamivudine based regimen (ABC/3TC + darunavir /ritonavir or ABC/3TC + raltegravir) in late presenter naive patients (with CD4 count 2016 a oggi PI in clinical trial An observational retrospective database analysis to evaluate Rallegravir based regimen in aged HIV patients (RalAge)"Clinical Trial Gov. Identifier: NCT02765776
2016 - Fellowship program Gilead 2016 per il progetto PRIMO Project: Infectious Disease and Movement Program: study of the effects of physical activity on HIV infection
2018 - PI per il progetto Role of HPV on life quality of HIV positive MSM
2018 - PI per il progetto Study of cardiovascular disease in HIV-positive patients: clinical implications of changes in the microbiota and serological markers of immunoactivation -
2018 - PI per il progetto Correlation Between Circulating ANGPTL2 Levels and Immunoactivation Status in a Cohort of HIV-Positive Patients
2018 - PI per il progetto Bacterial/viral interactions in infection and immunity: application of the flow cytometry technology in different clinical settings
2019 - PI per il progetto Targeting endocrine, metabolic, and vascular dysfunction in HIV : pharmacological modulation of the phosphodiesterase type-5 in clinical and experimental models
2020 - PI per il progetto Oral bacteriotherapy decontamination for the prevention of Ventilator Associated Pneumonia (VAP) in Intensive Care Unit patients
2020 - PI per il progetto Profile of the immune response of MBCs in the COVID-19 patient

Membro di editorial board

International Journal of Microbiology, Nutrients, Biomedicines, Current HIV Research, Microorganism, Sexes Journal, and others

Membro di Expert Panel of Italian Guidelines on HIV, Regional Guidelines on SARS-CoV2 and Region Guidelines on supportive therapies in neoplastic patients

Pubblicazioni scientifiche
Autore di 227 pubblicazioni scientifiche originali pubblicate su riviste internazionali peer reviewed. Autore di 26 capitoli in libri scientifici/medici

Indicatori bibliometrici
H-index 27
Number of citations 2713
Number of paper 227

Roma, 20_03_2021